Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
CSE:ZEAL
Watchlist
Price: 600 DKK -2.99%
Updated: May 20, 2024

Relative Value

The Relative Value of one ZEAL stock under the Base Case scenario is hidden DKK. Compared to the current market price of 600 DKK, Zealand Pharma A/S is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ZEAL Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
36
vs Industry
15
Median 3Y
56.4
Median 5Y
74.1
Industry
8.2
Forward
65.8
vs History
vs Industry
Median 3Y
-8.4
Median 5Y
-9.5
Industry
26.1
Forward
-88.9
vs History
vs Industry
Median 3Y
-10.3
Median 5Y
-13.3
Industry
24.8
vs History
vs Industry
Median 3Y
-9
Median 5Y
-10.4
Industry
23.4
vs History
7
vs Industry
3
Median 3Y
9.6
Median 5Y
6.8
Industry
2.6
vs History
33
vs Industry
13
Median 3Y
51.7
Median 5Y
73.2
Industry
7.4
Forward
62.9
vs History
23
vs Industry
9
Median 3Y
51.9
Median 5Y
51.9
Industry
9.1
vs History
vs Industry
Median 3Y
-9.1
Median 5Y
-11
Industry
4.6
Forward
-91
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-11
Industry
4.4
Forward
-64
vs History
vs Industry
Median 3Y
-9.5
Median 5Y
-10.7
Industry
6.4
vs History
vs Industry
Median 3Y
-9.3
Median 5Y
-10.4
Industry
3.8
vs History
4
vs Industry
1
Median 3Y
19.5
Median 5Y
31.3
Industry
4.9

Multiples Across Competitors

ZEAL Competitors Multiples
Zealand Pharma A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Zealand Pharma A/S
CSE:ZEAL
35B DKK 102.2 -49.8 -62.5 -59.7
US
Abbvie Inc
NYSE:ABBV
293.9B USD 5.4 49.4 13.8 21.3
US
Amgen Inc
NASDAQ:AMGN
167.6B USD 5.7 44.5 18.7 30.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115B USD 11.3 28.6 24 25.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
108.2B USD 8.3 28.1 22.7 25.2
AU
CSL Ltd
ASX:CSL
134.3B AUD 6.3 36.4 22 27.2
US
Gilead Sciences Inc
NASDAQ:GILD
84.4B USD 3.1 174.3 8.8 11.6
US
Moderna Inc
NASDAQ:MRNA
50.9B USD 9.9 -8.5 -9.4 -8.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
33.6B USD 3.5 28.8 14.6 18.3
KR
Celltrion Inc
KRX:068270
39.7T KRW 18.2 74.1 45.3 62.4
P/E Multiple
Earnings Growth
DK
Zealand Pharma A/S
CSE:ZEAL
Average P/E: 58
Negative Multiple: -49.8
N/A
US
Abbvie Inc
NYSE:ABBV
49.4
404%
US
Amgen Inc
NASDAQ:AMGN
44.5
82%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.6
49%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
28.1
47%
AU
CSL Ltd
ASX:CSL
36.4
84%
US
Gilead Sciences Inc
NASDAQ:GILD
174.3
75%
US
Moderna Inc
NASDAQ:MRNA
Negative Multiple: -8.5 N/A
US
Seagen Inc
NASDAQ:SGEN
Negative Multiple: -57.5 N/A
US
Biogen Inc
NASDAQ:BIIB
28.8
155%
KR
Celltrion Inc
KRX:068270
74.1
104%
EV/EBITDA Multiple
EBITDA Growth
DK
Zealand Pharma A/S
CSE:ZEAL
Average EV/EBITDA: 21.2
Negative Multiple: -62.5
N/A
US
Abbvie Inc
NYSE:ABBV
13.8
26%
US
Amgen Inc
NASDAQ:AMGN
18.7
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
59%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
22.7
50%
AU
CSL Ltd
ASX:CSL
22
54%
US
Gilead Sciences Inc
NASDAQ:GILD
8.8
18%
US
Moderna Inc
NASDAQ:MRNA
Negative Multiple: -9.4 N/A
US
Seagen Inc
NASDAQ:SGEN
Negative Multiple: -61.9 N/A
US
Biogen Inc
NASDAQ:BIIB
14.6
67%
KR
Celltrion Inc
KRX:068270
45.3
109%
EV/EBIT Multiple
EBIT Growth
DK
Zealand Pharma A/S
CSE:ZEAL
Average EV/EBIT: 27.7
Negative Multiple: -59.7
N/A
US
Abbvie Inc
NYSE:ABBV
21.3
88%
US
Amgen Inc
NASDAQ:AMGN
30.9
95%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.1
57%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.2
51%
AU
CSL Ltd
ASX:CSL
27.2
69%
US
Gilead Sciences Inc
NASDAQ:GILD
11.6
33%
US
Moderna Inc
NASDAQ:MRNA
Negative Multiple: -8.4 N/A
US
Seagen Inc
NASDAQ:SGEN
Negative Multiple: -55.8 N/A
US
Biogen Inc
NASDAQ:BIIB
18.3
71%
KR
Celltrion Inc
KRX:068270
62.4
188%

See Also

Discover More